Regenxbio RGNX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $15.23M-88.3% | $34.47M-40.1% | $58.8M+3.9% | $79.56M+37.7% | $130.1M+15.2% | ||
| $135.26M-1.8% | $195.6M+10.4% | $215.4M+8.3% | $243.74M+4.8% | $137.77M-39.0% | ||
| $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | $2.03M0.0% | ||
| $10.04M-44.8% | $26.38M+28.8% | $25.35M+7.4% | $20.2M-11.4% | $18.19M+14.9% | ||
| $11.54M+4.0% | $11.93M+31.5% | $12.94M+17.6% | $10.78M+7.5% | $11.09M-18.4% | ||
| $186.52M-40.5% | $281.28M+1.2% | $331.97M+5.9% | $373.75M+7.8% | $313.24M-20.8% | ||
| $101.87M-11.0% | $104.86M-10.8% | $107.52M-10.8% | $111.02M-10.4% | $114.5M-10.3% | ||
| $45.54M-12.6% | $47.16M-12.2% | $48.82M-11.7% | $50.47M-10.4% | $52.11M-9.5% | ||
| $5.51M+84.6% | $4.61M+15.3% | $4.27M-1.5% | $1.88M-36.2% | $2.99M-29.2% | ||
| $341.89M-30.4% | $453.03M-2.8% | $525.2M+1.2% | $581.03M+2.0% | $490.93M-22.0% | ||
| $21.21M+11.4% | $21.36M-6.3% | $22.27M+14.1% | $21.66M+32.3% | $19.04M-39.3% | ||
| $5.92M-56.4% | $10.45M+8,989% | $13.2M+9,063% | $13.98M+66,457% | $13.59M+104,423% | ||
| $7.87M-0.9% | $8.29M+4.9% | $9.07M+17.5% | $8.05M+10.2% | $7.94M+12.4% | ||
| $22.78M-13.4% | $18.94M— | $21.19M— | $23.8M— | $26.3M— | ||
| $71.11M-33.4% | $118.1M+14.4% | $124.57M+21.3% | $119.54M+21.6% | $106.73M-3.1% | ||
| $63.2M-12.1% | $65.22M-12.0% | $67.43M-11.7% | $69.65M-11.0% | $71.91M-10.3% | ||
| $622K-8.5% | $638K-82.4% | $648K-81.9% | $664K-81.2% | $680K-80.5% | ||
| $320.81M+48.0% | $350.3M+69.8% | $363.75M+67.1% | $367.35M+66.1% | $216.73M-9.1% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $1.24B+3.1% | $1.23B+3.1% | $1.22B+3.2% | $1.21B+3.4% | $1.2B+3.3% | ||
| -$1.22B-31.3% | -$1.13B-20.8% | -$1.06B-20.2% | -$996.94M-21.4% | -$926.07M-20.5% | ||
| -$870K-14.2% | -$687K+7.3% | -$652K-12.0% | -$750K+66.9% | -$762K+76.4% | ||
| $21.08M-92.3% | $102.73M-60.4% | $161.45M-46.4% | $213.68M-38.6% | $274.2M-29.8% | ||
| $341.89M-30.4% | $453.03M-2.8% | $525.2M+1.2% | $581.03M+2.0% | $490.93M-22.0% | ||
| $135.26M-1.8% | $195.6M+10.4% | $215.4M+8.3% | $243.74M+4.8% | $137.77M-39.0% | ||
| $14.44M-10.2% | $12.91M-6.3% | $19.47M+21.1% | $19.48M-17.1% | $16.08M-41.1% | ||
| $5.51M+84.6% | $4.61M+15.3% | $4.27M-1.5% | $1.88M-36.2% | $2.99M-29.2% | ||
| $420K-65.2% | $2.31M+388% | $2.77M+584% | $1.58M+241% | $1.21M+131% | ||
| $45.54M-12.6% | $47.16M-12.2% | $48.82M-11.7% | $50.47M-10.4% | $52.11M-9.5% | ||
| $45.54M-12.6% | $47.16M-12.2% | $48.82M-11.7% | $50.47M-10.4% | $52.11M-9.5% | ||
| $5.51M+84.6% | $4.61M+15.3% | $4.27M-1.5% | $1.88M-36.2% | $2.99M-29.2% | ||
| $45.54M-12.6% | $47.16M-12.2% | $48.82M-11.7% | $50.47M-10.4% | $52.11M-9.5% | ||
| $5.51M+84.6% | $4.61M+15.3% | $4.27M-1.5% | $1.88M-36.2% | $2.99M-29.2% | ||
| $22.78M-13.4% | $18.94M— | $21.19M— | $23.8M— | $26.3M— | ||
| $21.89M-7.2% | $38.39M+0.8% | $38.32M-21.2% | $35.56M-16.3% | $23.6M-28.8% | ||
| $14.23M— | $39.61M+15.4% | $41.72M— | $40.3M— | —— | ||
| $22.78M-13.4% | $18.94M— | $21.19M— | $23.8M— | $26.3M— | ||
| $22.78M-13.4% | $18.94M— | $21.19M— | $23.8M— | $26.3M— | ||
| $71.07M-11.0% | $73.5M-10.4% | $76.51M-9.0% | $77.7M-9.2% | $79.85M-8.5% | ||
| $1.24B+3.1% | $1.23B+3.1% | $1.22B+3.2% | $1.21B+3.4% | $1.2B+3.3% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| $11.54M+4.0% | $11.93M+31.5% | $12.94M+17.6% | $10.78M+7.5% | $11.09M-18.4% | ||
| $163.11M— | $147.41M+481% | $149.92M— | $153.69M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Regenxbio's total assets?
- Regenxbio (RGNX) holds $341.9M in total assets, down 30.4% year over year.
- How much debt does Regenxbio have?
- Regenxbio carries $71.1M in total debt against $21.1M of shareholders' equity, a debt-to-equity ratio of 3.37.
- How much cash does Regenxbio have?
- Regenxbio holds $15.2M in cash and equivalents.
- Can Regenxbio cover its short-term obligations?
- Its current ratio is 2.62 — current assets exceed current liabilities.
- Where does Regenxbio's balance sheet data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
